MDWD
MediWound Ltd

1,828
Loading...
Loading...
News
all
press releases
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of -123.64% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates
Nektar (NKTR) delivered earnings and revenue surprises of +5.75% and +3.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates
Stevanato (STVN) delivered earnings and revenue surprises of +9.09% and +4.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Here's What Could Help MediWound (MDWD) Maintain Its Recent Price Strength
MediWound (MDWD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks·3mo ago
News Placeholder
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
Zacks·5mo ago
News Placeholder
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates
Zacks·5mo ago
News Placeholder
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
chainwire·5mo ago

Latest MDWD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.